Fund profile by ISIN IE00BQ70R696
Invesco NASDAQ Biotech UCITS ETF
Research Invesco NASDAQ Biotech UCITS ETF by ISIN IE00BQ70R696: TER 0.40%, domicile Ireland, distributing, and 1-year price performance +34.6%.
ISINIE00BQ70R696
TER0.40%
DomicileIreland
Distribution policyDistributing
IndexNasdaq Biotechnology
Fund size432M
Holdings250
1-year price performance+34.6%
Exchange listings and tradability
| Ticker | Exchange | Currency | Country | Avg daily turnover | Avg daily shares |
|---|---|---|---|---|---|
| SBIO.L | LSE | USD | Ireland | €978K | 14,872 |
| SBIO.SW | SW | USD | Ireland | €515K | 8,004 |
| SBIO.MI | ETFP | EUR | Ireland | €373K | 5,934 |
| NBTK.DE | XETRADefault at German brokers | EUR | Ireland | €357K | 5,644 |
| SBIO.AS | XAMS | EUR | Ireland | €242K | 3,835 |
Avg daily turnover is the 90-day average, converted to euros so venues in different currencies can be compared; avg daily shares is the same window in units. The most traded listing is shown first. This fund trades on a German exchange. As of 2026-10-12.
Largest holdings
The 10 largest holdings make up 44.15% of the fund, which holds 250 positions in total. As of 2026-08-31.
| Holding | Symbol | Weight |
|---|---|---|
| Amgen, Inc. | AMGN | 8.66% |
| Vertex Pharmaceuticals | VRTX | 8.26% |
| Gilead Sciences, Inc. | GILD | 7.39% |
| Regeneron Pharmaceuticals, Inc. | REGN | 5.33% |
| Moderna | MRNA | 3.60% |
| Revolution Medicines | RVMD | 2.83% |
| Illumina, Inc. | ILMN | 2.09% |
| Alnylam Pharmaceuticals | ALNY | 2.08% |
| Biogen | BIIB | 2.07% |
| argenx | ARGX | 1.84% |
Performance is the historical price return of the representative listing. Distributions are excluded and past performance is not a forecast.